Karabulut ZT, Hacibekiroglu T, Koseoglu FD, Senol Arslan BC, et al. Real-world effectiveness and safety of fixed-duration frontline venetoclax-obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study. Leuk Res 2026;171:108342.
PMID: 42933070